wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38684435-DAD417AB-28F1-4A5B-AD64-8BD033F0EE7E
Q38684435-DAD417AB-28F1-4A5B-AD64-8BD033F0EE7E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38684435-DAD417AB-28F1-4A5B-AD64-8BD033F0EE7E
JAK2 inhibitors for myeloproliferative neoplasms: what is next?
P2860
Q38684435-DAD417AB-28F1-4A5B-AD64-8BD033F0EE7E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38684435-DAD417AB-28F1-4A5B-AD64-8BD033F0EE7E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
28cf1250f6b302c678adc3993521ead40b076053
P2860
A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis